FRA:AAQ1 - Deutsche Boerse Ag - DE000A3H2101 - Common Stock - Currency: EUR
FRA:AAQ1 (3/6/2025, 7:00:00 PM)
1.8
-0.07 (-3.74%)
The current stock price of AAQ1.DE is 1.8 EUR. In the past month the price decreased by -2.17%. In the past year, price increased by 140%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 28.81 | 214.85B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 69.31 | 166.86B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 39.18 | 133.56B | ||
1BSX.MI | BOSTON SCIENTIFIC CORP | 39.52 | 133.38B | ||
1MDT.MI | MEDTRONIC PLC | 17.48 | 113.17B | ||
2M6.DE | MEDTRONIC PLC | 17.56 | 110.81B | ||
1SHL.MI | SIEMENS HEALTHINEERS AG | 25.27 | 60.49B | ||
BOX.DE | BECTON DICKINSON AND CO | 16.4 | 60.33B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 23.49 | 59.08B | ||
1EW.MI | EDWARDS LIFESCIENCES CORP | 26.07 | 39.21B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 26.65 | 37.76B | ||
DC4.DE | DEXCOM INC | 48.5 | 28.81B |
aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 87 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
AAP IMPLANTATE
Lorenzweg 5
Berlin BERLIN DE
Employees: 87
Company Website: https://www.aap.de/
Investor Relations: https://www.aap.de/investoren
Phone: 4930750190
The current stock price of AAQ1.DE is 1.8 EUR. The price decreased by -3.74% in the last trading session.
The exchange symbol of AAP IMPLANTATE is AAQ1 and it is listed on the Deutsche Boerse Ag exchange.
AAQ1.DE stock is listed on the Deutsche Boerse Ag exchange.
AAP IMPLANTATE (AAQ1.DE) has a market capitalization of 25.04M EUR. This makes AAQ1.DE a Nano Cap stock.
AAP IMPLANTATE (AAQ1.DE) currently has 87 employees.
AAP IMPLANTATE (AAQ1.DE) has a support level at 1.73 and a resistance level at 1.89. Check the full technical report for a detailed analysis of AAQ1.DE support and resistance levels.
The Revenue of AAP IMPLANTATE (AAQ1.DE) is expected to grow by 15.04% in the next year. Check the estimates tab for more information on the AAQ1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AAQ1.DE does not pay a dividend.
AAP IMPLANTATE (AAQ1.DE) will report earnings on 2025-04-30, after the market close.
AAP IMPLANTATE (AAQ1.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.62).
ChartMill assigns a technical rating of 10 / 10 to AAQ1.DE. When comparing the yearly performance of all stocks, AAQ1.DE is one of the better performing stocks in the market, outperforming 98.84% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE. AAQ1.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months AAQ1.DE reported a non-GAAP Earnings per Share(EPS) of -0.62. The EPS decreased by -43.53% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -26.54% | ||
ROE | -41.5% | ||
Debt/Equity | 0.17 |
ChartMill assigns a Buy % Consensus number of 42% to AAQ1.DE. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 54.55% and a revenue growth 15.04% for AAQ1.DE